Stay updated on Safety and Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Safety and Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the Safety and Efficacy in Atopic Dermatitis Clinical Trial page
- Check3 days agoChange DetectedThe clinical trial record for ADSTEM Inj. in moderate-to-severe atopic dermatitis is now displayed, with details about the study’s design, participant eligibility, treatment arms, outcomes, and locations.SummaryDifference57%

- Check10 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0, and the study record still displays a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoChange DetectedA banner announces NIH website transition updates and says the agency is using “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check24 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1. The study record still shows a 403 error.SummaryDifference0.2%

- Check31 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check52 days agoChange DetectedThe study record page now shows a 403 Forbidden error, denying access to the content. This replaces the previously visible study details and blocks viewing the trial information.SummaryDifference19%

Stay in the know with updates to Safety and Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy in Atopic Dermatitis Clinical Trial page.